Regulatory & Policy
MOHAP approves first oral GLP-1 pill for UAE's 32% obesity rate, May 2026 launch
MOHAP has approved the UAE's first oral GLP-1 obesity drug, with pharmacies stocking from May 2026. The pill targets a market that grew 41% year-on-year since 2023.
4 Apr 2026 · 3 min read
